Pinterest (NYSE: PINS) reported better-than-expected revenue for the first quarter of 2019 but earnings missed estimates, sending shares tumbling over 15% in after-market hours on Thursday. The consensus estimate was for a loss of $0.15 per share on revenue of $200 million.
Revenues grew 54% year-over-year to $202 million, surpassing $200 million for the second consecutive quarter.
GAAP net loss was $41.4 million, or $0.33 per share, compared to $52.7 million, or $0.42 per share, in the prior-year period. Adjusted net loss was $40.3 million, or $0.32 per share.
CFO Todd Morgenfeld said, “We were particularly encouraged by the strength we saw in U.S. revenue and international user growth. Our strong revenue performance allowed us to expand net margin by 20 percentage points year-over-year, reflecting our continued prioritization and disciplined execution across our strategic priorities.”
During the quarter, revenue grew 51% to $187 million in the US while international revenues more than doubled to $15 million versus the year-ago period.
Total monthly active users (MAUs) increased 22% year-over-year to 291 million. The number of users in the US grew 6% to 85 million while the number of international users jumped 29% to 206 million.
Average revenue per user (ARPU) increased 26% to $0.73 worldwide. The majority of revenue came from the US with ARPU increasing 41% to $2.25. International ARPU grew 59% to $0.08.
For the full year of 2019, total revenue is expected to be $1.05 billion to $1.08 billion.
This is the company’s first earnings announcement since its IPO last month.
https://www.youtube.com/watch?v=50yUaLybUnA&t=667s China-based internet search firm Baidu Inc. (NASDAQ: BIDU) reported financial results for the second quarter of 2020 on Thursday after the market's close. Earnings exceeded analysts’ expectations, but the
Applied Materials' (NASDAQ: AMAT) earnings and revenue for the third quarter exceeded the market's views. Adjusted EPS of $1.06 and revenue of $4.40 billion in Q3, grew 43% and 23%,
A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or in the treatment of COVID-19. While these companies